- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06653881
Comparison of Conventional and Cu-NiTi Archwires Regarding Clinical Efficiency and Pain Intensity Using Prostaglandin E2 Biomarker During Alignment and Leveling
Study Overview
Status
Intervention / Treatment
Detailed Description
Title: Comparison of conventional and Cu-NiTi archwires regarding clinical efficiency and pain intensity using prostaglandin E2 biomarker during alignment and levelling: a randomized clinical trial" Rationale:An initial archwire should be effective in aligning the arches while resulting in minimal pain and root resorption. An ideal aligning archwire should have good formability, spring back, stiffness biocompatibility, low friction, and joinability and of low cost. Orthodontic force when exerted on teeth, activates the sensory receptors in periodontal tissues and results in a nociceptive impulse processing in both the central and peripheral nervous systems. A cascade of self-limiting inflammatory reactions including cellular, vascular, neural, and immunological reactions comes into act. In particular, the locally released prostaglandin binds to the periodontal sensory endings which generates a painful sensation resulting in orthodontic pain and tooth movement. PGE2, a cyclooxygenase product, is the best-known lipid mediator that contributes to pain. Thus, the evaluation of PGE2 concentration in GCF would provide an accurate and site-specific insight on objective pain. Furthermore, the VAS score will provide knowledge of the subjective pain perceived by the patients during the initial arch- wire placement.
Therefore, it is important to assess the time point at which the patient undergoing fixed orthodontic treatment will have the maximum pain and therefore in requirement of an analgesic. This is of particular concern during the initiation of treatment since the pain would be compounded with the natural anxiety associated with the orthodontic treatment.
Aims and Objectives: To determine and compare the alignment efficiency and pain perception of 0.016" A-NiTi vs 0.016" Cu-NiTi over 12 weeks period.
Setting: Department of Orthodontics and DentofacialOrthopaedics, PGIDS, Rohtak Study Design:Two-arm parallel single-blind randomized clinical trial. Time frame: 12 weeks after initial archwire placement.
Population/participant:
Inclusion criteria:-Orthodontic patients to be treated with fixed orthodontic treatment requiring non-extraction treatment plan, moderate crowding between 4-6mm in the mandibular anterior region, between 18 and 25 years of age with full complement of teeth erupted to the occlusal level (excluding third molars)optimal periodontal condition and good oral hygiene.
Exclusion Criteria:- craniofacial anomalies and syndromes, congenitally missing teeth (excluding third molars) or severe facial asymmetries ,any systemic disease affecting bone and general growth ,acute or chronic medical patients that are under medications and would affect tooth movement, known allergy to metal and components used in orthodontic treatment.
Sample size:The sample size for the proposed study was calculated by using the formula. Total sample size = N = 2σ2(Zβ+ Zα/2) 2 / (difference)2. A sample size of 13 patients was calculated by using the above formula at confidence interval 95% with power 80%. Accounting for a 10% drop out rate, 15 patients will be enrolled in each group.
Method of study: Pre- treatment records will be taken will be selected from patients reporting to the Department of Orthodontics and Dentofacial Orthopedics, PGIDS, Rohtak. Subjects satisfying inclusion criteria will be divided into two groups.
Group 1 (G1) 0.016"A-NiTi - In this group, pretreament orthodontic records (T0) of all the patients undergoing study will be taken before bonding. Before bonding, teeth will be isolated and oral prophylaxis will be performed. Enamel will be etched with 37% phosphoric acid gel, rinsed with water and air dried till a frosty appearance of the etched surface was evident. Bonding agent will be applied and cured using LED curing light unit. A conventional orthodontic adhesive will be used to bond brackets with 0.022 ̎×0.028 inch slot. 0.016"A-NiTi initial archwire will be securely ligated with elastomeric modules.
Group 2 (G2) 0.016" Cu-NiTi-In this group, pretreament orthodontic records (T0) of all the patients undergoing study will be taken before bonding. Before bonding, teeth will be isolated and oral prophylaxis will be performed. Enamel will be etched with 37% phosphoric acid gel, rinsed with water and air dried till a frosty appearance of the etched surface was evident. Bonding agent will be applied and cured using LED curing light unit. A conventional orthodontic adhesive will be used to bond brackets with 0.022 ̎×0.028 inch slot. 0.016" Cu-NiTi archwire will be securely ligated with elastomeric modules.
Outcome Measures: Changes in the following parameters -little's irregularity index will be measured by model scanning in both the groups. Assessment of these parameters will be done at T0 (baseline data), T1(6 weeks after initial archwire placement), T2(12 weeks after initial archwire placement). Gingival crevicular fluid (GCF) will be collected 1 hr before bonding in lower arch , 24 hours after initial arch wire placement , 48 hrs after initial arch wire placement , 72hrs after initial arch wire placement for assessing PGE2 levels. Pain assessment will be done at 24 hours after initial archwire placement, 48 hours after initial archwire placement, 72 hours after initial archwire placement.
Statistical Analysis: Descriptive statistics and inferential statistics will be used. Data will be checked for normality. In all the analysis, the level of significance will be set at 5 percent.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Haryana
-
Rohtak, Haryana, India, 124001
- PGIDS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Orthodontic patients to be treated with fixed orthodontic treatment requiring non-extraction treatment plan.
- Patients' with pre-treatment moderate crowding between 4-6mm in the mandibular anterior region assessed with Little's Irregularity index.
- Male and female patients between 18 and 25 years of age with full complement of teeth erupted to the occlusal level (excluding third molars).
- Non syndromic patients and no impaction of teeth except third molars.
- No history of previous orthodontic treatment.
- Optimal periodontal condition and good oral hygiene.
Exclusion Criteria:
- Acute or chronic medical patients that are under medications and would affect tooth movement.
- Medical conditions that contraindicate orthodontic treatment.
- Craniofacial anomalies and syndromes, congenitally missing teeth (excluding third molars) or severe facial asymmetries.
- Any systemic disease affecting bone and general growth.
- Patients' with known allergy to metal and components used in orthodontic treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: GROUP 1: Patient receiving 0.016" A-NiTi (Conventional)archwire.
Pretreament orthodontic records (T0) of all the patients undergoing study will be taken before bonding.
Before bonding, teeth will be isolated and oral prophylaxis will be performed.
Enamel will be etched with 37% phosphoric acid gel, rinsed with water and air dried till a frosty appearance of the etched surface was evident.
Bonding agent will be applied and cured using LED curing light unit.
A conventional orthodontic adhesive will be used to bond brackets with 0.022 ̎×0.028 inch slot.
In this group ,1 0.016"A-NiTi initial archwire will be securely ligated .
|
Alignment efficiency of the archwires will be compared using little's irregularity index between the two groups
|
|
Experimental: GROUP 2:Patient receiving 0.016" Cu-NiTi archwire.
. Pretreament orthodontic records (T0) of all the patients undergoing study will be taken before bonding.
Before bonding, teeth will be isolated and oral prophylaxis will be performed.
Enamel will be etched with 37% phosphoric acid gel, rinsed with water and air dried till a frosty appearance of the etched surface was evident.
Bonding agent will be applied and cured using LED curing light unit.
A conventional orthodontic adhesive will be used to bond brackets with 0.022 ̎×0.028 inch slot.
In this group 0.016" Cu-NiTi archwire will be securely ligated.
|
Alignment efficiency of the archwires will be compared using little's irregularity index between the two groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ARCH ALIGNMENT
Time Frame: T0 - Baseline records, at the time before treatment T1 - Records at 6th week after wire placement T2 - Records at 12th week after wire placement
|
Alginate impression(Algitex impression material,Dental products of India) were taken and models were poured immediately using dental gypsum type III orthokal material(Kalabhai,karson,India) Later cast were scanned using three dimensional intra oral scanner (iTero Element Flex Portable Intraoral Scanner) & STL files were obtained. STL files were imported into the Geomagic Freeform software v2022.0.34 (3D Systems, Rockhil,Sc) )& was used to digitally calculate the measurements for alignment efficiency . THREE-DIMENSIONALSUPERIMPOSITION ANALYSIS by using a 3D software program (Geomagic Freeform software v2022.0.34). The amount of alignment achieved during the study using each different archwire was measured in all three dimensions. Arizona).For precise measurement, three anatomical reference points were identified - meiolabioincisal point ,midpoint on the cusp tip/incisal edge ,distolabioincisal point were taken on each tooth & average was calculated |
T0 - Baseline records, at the time before treatment T1 - Records at 6th week after wire placement T2 - Records at 12th week after wire placement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SUBJECTIVE PAIN ASSESSMENT BY VISUAL ANALOG SCALE
Time Frame: 1. 24 hours after initial archwire placement. 2. 48 hours after initial arch wire placement 2. 72 hours after initial arch wire placement
|
Participants were asked to record the maximum pain experienced each day.
The VAS recording sheet, containing three separate scales (one per day), was provided at the time of bonding.
Standardized oral hygiene instructions were given to all participants to mark the point on the line corresponding to their maximum daily pain, where 0 indicated "no pain" 5 moderate pain and 10 indicated "severe pain."
To promote adherence, daily reminders were sent via phone call or text message.
Completed recording sheets were collected at the subsequent follow-up visit.
|
1. 24 hours after initial archwire placement. 2. 48 hours after initial arch wire placement 2. 72 hours after initial arch wire placement
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
GCF COLLECTION
Time Frame: 1. 1 hour before bonding in lower arch 2. 24 hours after initial arch wire placement 2. 48 hours after initial arch wire placement 2. 72 hours after initial arch wire placement
|
At the sites of sample collection, supragingival plaque was removed using sterile curettes, and the area was isolated with cotton rolls and gently air-dried to prevent contamination. To minimize mechanical trauma to gingival tissues, a sterile, standardized Perio-paper strip (Oraflow, New York, USA)(Figure- 8) was gently inserted into the gingival sulcus of the most crowded region until mild resistance was felt(Figure9). Strips contaminated with blood were discarded and replaced. The GCF samples, collected one hour prior to bonding to serve as baseline data .The collected Perio-paper strips were immediately placed into labeled Eppendorf tubes containing 100 μL of phosphate buffer solution, with patient identification clearly marked. The samples were transported in a temperature-controlled transport box (Figure11)and stored at -80 °C(Figure12) until further analysis. Before processing, the samples were centrifuged at 20 min at 1000×g at 2-8℃ to remove particulate matter. Subsequently, |
1. 1 hour before bonding in lower arch 2. 24 hours after initial arch wire placement 2. 48 hours after initial arch wire placement 2. 72 hours after initial arch wire placement
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RAGHAVI V
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Perception
-
Mouetaz KheirallahActive, not recruiting
-
Shatha Musaad AlharthiNot yet recruiting
-
Cairo UniversityNot yet recruitingPain Perception of the New Device
-
King Abdulaziz UniversityCompletedPain Perception of the New DeviceSaudi Arabia
-
Medical University of ViennaRecruitingTransgender Persons | Pain Threshold | Sex Hormones | Perception of PainAustria
-
Universidad Autonoma de San Luis PotosíCompletedPain Perception | Topical Anesthesia | Local Anesthetic InfiltrationMexico
-
Stéphane PotvinCompleted
-
University of GiessenCompletedPain PerceptionGermany
-
Aga Khan University Hospital, PakistanCompleted
-
Rambam Health Care CampusWithdrawnExperimental Pain PerceptionIsrael
Clinical Trials on ARCHWIRE
-
Damascus UniversityCompletedCLASS II DIVISION 1 MALOCCLUSIONSyria
-
Cairo UniversityUnknownLeveling and Alignment of Teeth
-
Jordan University of Science and TechnologyCompletedOrthodontic ApplianceJordan
-
University of Colorado, DenverRecruitingOrthodontic Discomfort | Pain, OrofacialUnited States
-
Fundación Universitaria CIEOUnknownCrowding of Anterior Mandibular TeethColombia
-
University of North Carolina, Chapel HillN2 Biomedical LLCWithdrawn
-
Mansoura UniversityActive, not recruitingCanine RetractionEgypt
-
Al-Azhar UniversityNot yet recruitingDeep Bite Malocclusion
-
Jordan University of Science and TechnologyCompleted
-
Cairo UniversityCompletedOrthodontic Appliance ComplicationEgypt